1. What should we know about the person behind a TTO?

   • Floortje van Nooten
   • Jan Busschbach
   • Werner Brouwer

   Editorial 18 April 2018 Pages: 1207 - 1211

2. Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment

   • T. Lehnert
   • O. H. Günther
   • H. H. König

   Original Research 06 April 2018 Pages: 1213 - 1223

   

3. Some adjustments to the human capital and the friction cost methods

   • Antonis Targoutzidis

   Original Research 21 March 2018 Pages: 1225 - 1228

4. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach

   • Ann-Kathrin Richter
   • Ludger Klimek
   • Janine Biermann-Stallwitz

   Original Research 24 March 2018 Pages: 1229 - 1242

   

5. The economic impact of multiple sclerosis to the patients and their families in Norway

   • B. Svendsen
   • N. Grytten
   • K-M. Myhr

   Original Research Open access 21 April 2018 Pages: 1243 - 1257

   

6. Tackling the chronic disease burden: are there co-benefits from climate policy measures?

   • Désirée Vandenberghe
   • Johan Albrecht

   Original Research 26 April 2018 Pages: 1259 - 1283

   

7. Health inequality indices and exogenous risk factors: an illustration on Luxembourgish workers

   • Stéphane Mussard
   • Maria Noel Pi Alperin
   • Véronique Thireau

   Original Research 03 May 2018 Pages: 1285 - 1301

   

8. Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort

   • Rebecca Forster
   • Aran Ratcliffe
   • William C. N. Dunlop

   Original Research Open access 12 May 2018 Pages: 1303 - 1318

   

9. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students

   • Jonah Popp
   • John A. Nyman
   • Janet L. Thomas

   Original Paper 23 April 2018 Pages: 1319 - 1333

   

10. People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case

    • Caroline Orset

    Original Paper 23 April 2018 Pages: 1335 - 1350

    

11. Examining unpriced risk heterogeneity in the Dutch health insurance market

    • A. A. Withagen-Koster
    • R. C. van Kleef
    • F. Eijkenaar

    Original Paper Open access 18 April 2018 Pages: 1351 - 1363

    

12. Economic evaluation of Zepatier for the management of HCV in the Italian scenario

    • F. R. Rolli
    • M. Ruggeri
    • A. Cicchetti

    Original Paper 25 April 2018 Pages: 1365 - 1374